Literature DB >> 29467142

The Authors Reply.

Morgane Solis1,2, Aurélie Velay1,2, Bruno Moulin2,3, Sophie Caillard2,3, Samira Fafi-Kremer4,2.   

Abstract

Keywords:  antibodies; infection; polyomavirus

Mesh：

Substances：

Year:  2018        PMID： 29467142      PMCID： PMC5967774          DOI： 10.1681/ASN.2018010027

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  5 in total

1.  Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.

Authors:  Morgane Solis; Aurélie Velay; Raphaël Porcher; Pilar Domingo-Calap; Eric Soulier; Mélanie Joly; Mariam Meddeb; Wallys Kack-Kack; Bruno Moulin; Siamak Bahram; Françoise Stoll-Keller; Heidi Barth; Sophie Caillard; Samira Fafi-Kremer
Journal:  J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 10.121

2.  JC polyomavirus mutants escape antibody-mediated neutralization.

Authors:  Upasana Ray; Paola Cinque; Simonetta Gerevini; Valeria Longo; Adriano Lazzarin; Sven Schippling; Roland Martin; Christopher B Buck; Diana V Pastrana
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

3.  BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.

Authors:  Diana V Pastrana; Upasana Ray; Thomas G Magaldi; Rachel M Schowalter; Nicolas Çuburu; Christopher B Buck
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

4.  Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.

Authors:  Diana V Pastrana; Daniel C Brennan; Nicolas Cuburu; Gregory A Storch; Raphael P Viscidi; Parmjeet S Randhawa; Christopher B Buck
Journal:  PLoS Pathog       Date:  2012-04-12       Impact factor: 6.823

Review 5.  Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.

Authors:  Patrizia Comoli; Michela Cioni; Sabrina Basso; Chiara Gagliardone; Leonardo Potenza; Enrico Verrina; Mario Luppi; Marco Zecca; Gian Marco Ghiggeri; Fabrizio Ginevri
Journal:  Clin Dev Immunol       Date:  2013-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.